Evidence map›Paper›PMID 20211000›Full record

ArticleJournal of medical case reports2010

Nocardia farcinica lung infection in a patient with cystic fibrosis: a case report.

Fadi Bittar, Nathalie Stremler, Jean-Pierre Audié, Jean-Christophe Dubus, Jacques Sarles, Didier Raoult, Jean-Marc Rolain

Open access · goldAbstract read
In one paragraph

Article in Journal of medical case reports, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. CRISPR/Cas12a-Based Diagnostic Platform Accurately DetectsFrontiers in cellular and infection microbiology · 2022
    Article
  3. A 58-Year-Old Female with Progressive Cough and Right Shoulder Pain.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2016
    Article
  4. Article
  5. Nocardia Colonization: A Risk Factor for Lung Deterioration in Cystic Fibrosis Patients?Medical science monitor : international medical journal of experimental and clinical research · 2015
    Article
  6. Article
  7. Article
  8. Article
  9. A case of Nocardia transvalensis pneumonia in a 19-year-old cystic fibrosis patient.Lung India : official organ of Indian Chest Society · 2012
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Fadi BittarUnité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), CNRS-IRD, UMR 6236, Faculté de Médecine et de Pharmacie, Université de la Méditerranée, Boulevard Jean Moulin, 13385 Marseille cedex 5, France. jean-marc.rolain@univmed.fr.
Nathalie Stremler
Jean-Pierre Audié
Jean-Christophe Dubus
Jacques Sarles
Didier Raoult
Jean-Marc Rolain
Hôpital de la Timone · FRInstitut de Recherche pour le Développement · FRCentre National de la Recherche Scientifique · FRLaboratoire de Chimie Bactérienne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRespiratory tract infections are the major causes of morbidity and mortality in patients with cystic fibrosis. Nocardia are rarely implicated in these infections and few reports of the involvement of this species are found in the literature. CASE PRESENTATION: We describe a case of lung infection followed by chronic colonization of trimethoprim and sulfamethoxazole resistant Nocardia farcinica in a patient with cystic fibrosis. The chronic colonization of this uncommon bacterium in patients with cystic fibrosis was proved using a newly developed real-time polymerase chain reaction assay, which indicates that this bacterium, despite treatment, is difficult to eradicate.

conclusionOur case report confirms that this organism can be recovered in persons with cystic fibrosis. Its eradication is necessary especially if the patient is to undergo lung transplantation.

Identifiers

PMID20211000
PMCPMC2844380
OpenAlexW1973547129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.